Vimarsana
Biggest News Aggregation in the World

Page 29 - Groupa Streptococcus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Groupa Streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Groupa Streptococcus Today - Breaking & Trending Today

Cantor Fitzgerald Equities Analysts Raise Earnings Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) - Vimarsana News

Cantor Fitzgerald Equities Analysts Raise Earnings Estimates for Vaxcyte, Inc. (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2023 EPS estimates for shares of Vaxcyte in a report released on Wednesday, August 9th. Cantor Fitzgerald analyst L. Chen now expects that the company will post earnings per share of ($3.05) for the year, up from their prior estimate of ($3.15). […]

FY2023 EPS Estimates for Vaxcyte, Inc. Lifted by Analyst (NASDAQ:PCVX) - Vimarsana News

FY2023 EPS Estimates for Vaxcyte, Inc. Lifted by Analyst (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Cantor Fitzgerald increased their FY2023 EPS estimates for shares of Vaxcyte in a report released on Wednesday, August 9th. Cantor Fitzgerald analyst L. Chen now forecasts that the company will post earnings per share of ($3.05) for the year, up from their previous forecast of ($3.15). The consensus […]

Source: wkrb13.com
Q3 2023 EPS Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) Reduced by Analyst - Vimarsana News

Q3 2023 EPS Estimates for Vaxcyte, Inc. (NASDAQ:PCVX) Reduced by Analyst

Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) – Leerink Partnrs cut their Q3 2023 EPS estimates for Vaxcyte in a research report issued on Sunday, August 13th. Leerink Partnrs analyst D. Risinger now anticipates that the company will earn ($0.73) per share for the quarter, down from their previous estimate of ($0.70). The consensus estimate for […]

Needham & Company LLC Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX) - Vimarsana News

Needham & Company LLC Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX)

Vaxcyte (NASDAQ:PCVX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Wednesday, Benzinga reports. They presently have a $58.00 price target on the stock. Needham & Company LLC’s target price would suggest a potential upside of 22.80% from the […]

Asymptomatic throat carriage is the key to transmission of Group A Streptococcus infections - Vimarsana News

Asymptomatic throat carriage is the key to transmission of Group A Streptococcus infections

Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection.